\
&
Contact us
\
&
Contact us
This was 8 months ago
LocationMetz (Frankrijk)
The cluster 6 and the missions work programme are expected to be published in the beginning of April. Many organisations or companies who are interested in these calls are looking for partners to form a consortium.
To facilitate this search, several Enterprise Europe Network partners will organize a brokerage event on the 25th of March in Metz (northeast of France). During the event there will also be workshops and pitches.
Participation is free of charge but the event is only on-site (not online) and you can register until the 24th of March. You can find all the details on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
